Puma Biotechnology, Inc. (PBYI)
10.42
+0.22
(+2.16%)
USD |
NASDAQ |
Oct 15, 10:01
Puma Biotechnology Total Long Term Debt (Quarterly) : 4.367M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.367M |
| March 31, 2026 | 15.83M |
| December 31, 2025 | 27.23M |
| September 30, 2025 | 38.58M |
| June 30, 2025 | 44.87M |
| March 31, 2025 | 55.98M |
| December 31, 2024 | 68.54M |
| September 30, 2024 | 81.02M |
| June 30, 2024 | 93.43M |
| March 31, 2024 | 105.76M |
| December 31, 2023 | 106.69M |
| September 30, 2023 | 107.59M |
| June 30, 2023 | 108.48M |
| March 31, 2023 | 109.34M |
| December 31, 2022 | 110.14M |
| September 30, 2022 | 110.92M |
| June 30, 2022 | 111.66M |
| March 31, 2022 | 112.39M |
| December 31, 2021 | 113.07M |
| September 30, 2021 | 113.71M |
| June 30, 2021 | 117.96M |
| March 31, 2021 | 117.91M |
| December 31, 2020 | 117.86M |
| September 30, 2020 | 117.79M |
| June 30, 2020 | 117.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 117.68M |
| December 31, 2019 | 117.60M |
| September 30, 2019 | 117.52M |
| June 30, 2019 | 117.43M |
| March 31, 2019 | 177.49M |
| December 31, 2018 | 151.89M |
| September 30, 2018 | 121.05M |
| June 30, 2018 | 120.27M |
| March 31, 2018 | 48.56M |
| December 31, 2017 | 48.48M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 23.32M |
| Arcutis Biotherapeutics, Inc. | 114.14M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Savara, Inc. | 30.11M |